Syros Pharmaceuticals (SYRS) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Syros Pharmaceuticals Revenue Highlights


Latest Revenue (Y)

$9.94M

0

Syros Pharmaceuticals Revenue by Period


Syros Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$9.94M-33.23%
2022-12-31$14.88M-36.65%
2021-12-31$23.49M55.62%
2020-12-31$15.09M661.50%
2019-12-31$1.98M-3.32%
2018-12-31$2.05M86.19%
2017-12-31$1.10M247.32%
2016-12-31$317.00K-
2015-12-31$317.00K100.00%
2014-12-31--

Syros Pharmaceuticals generated $9.94M in revenue during NA 2023, up -33.23% compared to the previous quarter, and up 484.68% compared to the same period a year ago.

Syros Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$386.00K-89.74%
2023-09-30$3.76M32.79%
2023-06-30$2.83M-4.10%
2023-03-31$2.95M-154.03%
2022-12-31$-5.47M-240.50%
2022-09-30$3.89M-38.00%
2022-06-30$6.28M14.80%
2022-03-31$5.47M-29.93%
2021-12-31$7.80M36.95%
2021-09-30$5.70M10.36%
2021-06-30$5.16M6.94%
2021-03-31$4.83M-15.30%
2020-12-31$5.70M48.88%
2020-09-30$3.83M20.08%
2020-06-30$3.19M34.01%
2020-03-31$2.38M368.31%
2019-12-31$508.00K-8.96%
2019-09-30$558.00K20.78%
2019-06-30$462.00K1.76%
2019-03-31$454.00K-49.16%
2018-12-31$893.00K116.75%
2018-09-30$412.00K9.87%
2018-06-30$375.00K1.35%
2018-03-31$370.00K100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30--100.00%
2017-03-31$1.10M247.32%
2016-12-31$317.00K100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30--100.00%
2015-06-30$317.00K100.00%
2015-03-31--

Syros Pharmaceuticals generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Syros Pharmaceuticals Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
CHRSCoherus BioSciences$257.24M$64.98M
XNCRXencor$168.34M$16.96M
SPROSpero Therapeutics$96.73M$10.20M
RGNXREGENXBIO$90.24M$22.30M
IDYAIDEAYA Biosciences$23.39M-
SYRSSyros Pharmaceuticals$9.94M-
STOKStoke Therapeutics$8.78M$4.22M
BOLTBolt Biotherapeutics$7.88M$1.27M
KZRKezar Life Sciences$7.00M-
KRONKronos Bio$6.29M$2.69M
CRNXCrinetics Pharmaceuticals$4.01M$640.00K
FIXXQ32 Bio$1.16M-
KROSKeros Therapeutics$151.00K$83.00K
BDTXBlack Diamond Therapeutics--
GRCLGracell Bio--
PASGPassage Bio--
SNDXSyndax Pharmaceuticals-$3.50M
RNXTRenovoRx--
NLTXNeurogene--
LRMRLarimar Therapeutics--
SRZNSurrozen--
QNRXQuoin Pharmaceuticals--
KTTAPasithea Therapeutics--

SYRS Revenue FAQ


Syros Pharmaceuticals's yearly revenue for 2023 was $9.94M, representing a decrease of -33.23% compared to 2022. The company's yearly revenue for 2022 was $14.88M, representing a decrease of -36.65% compared to 2021. SYRS's yearly revenue for 2021 was $23.49M, representing an increase of 55.62% compared to 2020.

Syros Pharmaceuticals's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). SYRS's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023).

Syros Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was -57.70%, and for the last 5 years (2019-2023) was 401.31%.